Structural insights into the broad-spectrum antiviral target endoplasmic reticulum alpha-glucosidase II
Targeting the host-cell endoplasmic reticulum quality control (ERQC) pathway is an effective broad-spectrum antiviral strategy. The two ER resident α-glucosidases whose sequential action permits entry in this pathway are the targets of glucomimetic inhibitors. Knowledge of the molecular details of t...
Principais autores: | Zitzmann, N, Caputo, AT, Alonzi, DS, Kiappes, JL, Struwe, WB, Cross, A, Basu, S, Darlot, B, Roversi, P |
---|---|
Outros Autores: | Hilgenfeld, R |
Formato: | Book section |
Idioma: | English |
Publicado em: |
Springer
2018
|
Registros relacionados
-
Structural studies of Endoplasmic Reticulum Glucosidase II
por: Caputo, A, et al.
Publicado em: (2015) -
Structures of mammalian ER α-glucosidase II capture the binding modes of broad-spectrum iminosugar antivirals
por: Caputo, A, et al.
Publicado em: (2016) -
Investigating the inhibition of endoplasmic reticulum α-Glucosidase II for the development of broad-spectrum antivirals
por: Bremner, FR
Publicado em: (2023) -
ToP-DNJ, a selective inhibitor of endoplasmic reticulum α-glucosidase II exhibiting anti-flaviviral activity
por: Kiappes, JL, et al.
Publicado em: (2017) -
Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4
por: Warfield, KL, et al.
Publicado em: (2016)